Boeing CEO to step down in broad management shake-up as 737 Max crisis weighs on aerospace giant
Boeing CEO Dave Calhoun will step down at the end of 2024 in part of a broad management shakeup for the embattled aerospace giant.
As Trump’s $454 million fraud judgment deadline looms, son Eric gripes ‘they want to bankrupt him’
Donald Trump is trying to hold off a massive New York fraud judgment as he seeks to unseat President Joe Biden from the White House in November’s election.
Consumer advocates — and even some Realtors — hail NAR settlement: ‘We’ve opened up the entire industry to competition’
Greater competition for homebuyers is likely to result in lower costs across the board, experts say.
Why the $183 billion video game industry can’t quit microtransactions
Two of the largest video game companies in the U.S. now make the vast majority of their money from live-service games, subscriptions and in-game spending.
Former Justice Stephen Breyer: It’s ‘possible’ Dobbs could be overruled one day
The former Supreme Court Justice sat down with NBC News’ “Meet the Press” ahead of the release of his new book.
Trump says ‘I love Truth Social’ one day after DWAC stock plunges on social media merger vote
Donald Trump faces big civil judgments, but the merger of Digital World Acquisition and his social media company could net him a $3 billion windfall.
The last time a Trump company went public it didn’t go well for investors
Trump made millions in the 1990s when his casino company went public. Investors lost a fortune.
Why auto insurance rates are skyrocketing in the U.S.
The average annual premium for full coverage auto insurance in the U.S. rose 26% from 2023 to 2024, according to Bankrate.
What investors should know about the U.S. easing vehicle emissions rules
The EPA’s percentage targets for EV adoption are not mandates but expectations for how automakers can meet its new regulations.
Here’s how much people are willing to spend on weight loss drugs, according to a new survey
Some patients are willing to pay more for GLP-1 weight loss drugs like Wegovy than others — and it’s strongly correlated to their annual income.
